Skip to main content
Gut logoLink to Gut
. 1974 Apr;15(4):324–334. doi: 10.1136/gut.15.4.324

Iron and the liver.

M Barry
PMCID: PMC1412957  PMID: 4600337

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott D. F., Gresham G. A. Arthropathy in transfusional siderosis. Br Med J. 1972 Feb 12;1(5797):418–419. doi: 10.1136/bmj.1.5797.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BECKER D., MILLER M. Presence of diabetic glomerulosclerosis in patients with hemochromatosis. N Engl J Med. 1960 Aug 25;263:367–373. doi: 10.1056/NEJM196008252630801. [DOI] [PubMed] [Google Scholar]
  3. BELL E. T. The relation of portal cirrhosis to hemochromatosis and to diabetes mellitus. Diabetes. 1955 Nov-Dec;4(6):435–446. doi: 10.2337/diab.4.6.435. [DOI] [PubMed] [Google Scholar]
  4. BLOCK M., MOORE G., WASI P., HAIBY G. HISTOGENESIS OF THE HEPATIC LESION IN PRIMARY HEMOCHROMATOSIS: WITH CONSIDERATION OF THE PSEUDO-IRON DEFICIENT STATE PRODUCED BY PHLEBOTOMIES. Am J Pathol. 1965 Jul;47:89–123. [PMC free article] [PubMed] [Google Scholar]
  5. BOTHWELL T. H., ISAACSON C. Siderosis in the bantu. A comparison of incidence in males and females. Br Med J. 1962 Feb 24;1(5277):522–524. doi: 10.1136/bmj.1.5277.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Balcerzak S. P., Mintz D. H., Westerman M. P. Diabetes mellitus and idiopathic hemochromatosis. Am J Med Sci. 1968 Jan;255:53–62. doi: 10.1097/00000441-196801000-00010. [DOI] [PubMed] [Google Scholar]
  7. Balcerzak S. P., Westerman M. P., Heinle E. W., Taylor F. H. Measurement of iron stores using deferoxamine. Ann Intern Med. 1968 Mar;68(3):518–525. doi: 10.7326/0003-4819-68-3-518. [DOI] [PubMed] [Google Scholar]
  8. Balcerzak S. P., Westerman M. P., Lee R. E., Doyle A. P. Idiopathic hemochromatosis. A study of three families. Am J Med. 1966 Jun;40(6):857–873. doi: 10.1016/0002-9343(66)90201-4. [DOI] [PubMed] [Google Scholar]
  9. Bannerman R. M., Keusch G., Kreimer-Birnbaum M., Vance V. K., Vaughan S. Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. Am J Med. 1967 Mar;42(3):476–486. doi: 10.1016/0002-9343(67)90276-8. [DOI] [PubMed] [Google Scholar]
  10. Barry M., Flynn D. M., Letsky E. A., Risdon R. A. Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress. Br Med J. 1974 Apr 6;2(5909):16–20. doi: 10.1136/bmj.2.5909.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Barry M. Iron and chronic liver disease. J R Coll Physicians Lond. 1973 Oct;8(1):52–62. [PMC free article] [PubMed] [Google Scholar]
  12. Barry M., Scheuer P. J., Sherlock S., Ross C. F., Williams R. Hereditary spherocytosis with secondary haemochromatosis. Lancet. 1968 Aug 31;2(7566):481–485. doi: 10.1016/s0140-6736(68)90648-x. [DOI] [PubMed] [Google Scholar]
  13. Barry M., Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet. 1971 Jan 16;1(7690):100–103. doi: 10.1016/s0140-6736(71)90838-5. [DOI] [PubMed] [Google Scholar]
  14. Berry E. M., Miller J. P. Hereditary spherocytosis, haemochromatosis, diabetes mellitus and chondrocalcinosis. Proc R Soc Med. 1973 Jan;66(1 Pt 1):9–10. [PMC free article] [PubMed] [Google Scholar]
  15. CHARLTON R. W., JACOBS P., SEFTEL H., BOTHWELL T. H. EFFECT OF ALCOHOL ON IRON ABSORPTION. Br Med J. 1964 Dec 5;2(5422):1427–1429. doi: 10.1136/bmj.2.5422.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Charlton R. W., Abrahams C., Bothwell T. H. Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients. Arch Pathol. 1967 Feb;83(2):132–140. [PubMed] [Google Scholar]
  17. Charlton R. W., Hawkins D. M., Mavor W. O., Bothwell T. H. Hepatic storage iron concentrations in different population groups. Am J Clin Nutr. 1970 Mar;23(3):358–370. doi: 10.1093/ajcn/23.3.358. [DOI] [PubMed] [Google Scholar]
  18. Conn H. O. Portacaval anastomosis and hepatic hemosiderin deposition: a prospective, controlled investigation. Gastroenterology. 1972 Jan;62(1):61–72. [PubMed] [Google Scholar]
  19. Cáp J., Lehotská V., Mayerová A. Kongenitálna atransferinémia u 11-mesacného dietata. Cesk Pediatr. 1968 Oct;23(11):1020–1025. [PubMed] [Google Scholar]
  20. DAVIS A. E., BIGGS J. C. IRON ABSORPTION IN HAEMOCHROMATOSIS AND CIRRHOSIS OF THE LIVER. Australas Ann Med. 1964 Aug;13:201–203. doi: 10.1111/imj.1964.13.3.201. [DOI] [PubMed] [Google Scholar]
  21. DELBARRE F. [Osteoporosis in hemochromatosis]. Sem Hop. 1960 Dec 20;36:3279–3294. [PubMed] [Google Scholar]
  22. DELLER D. J. IRON-59 ABSORPTION MEASUREMENTS BY WHOLE-BODY COUNTING: STUDIES IN ALCOHOLIC CIRRHOSIS, HEMOCHROMATOSIS, AND PANCREATITIS. Am J Dig Dis. 1965 Mar;10:249–258. doi: 10.1007/BF02233755. [DOI] [PubMed] [Google Scholar]
  23. DOBERNECK R. C., KLINE D. G., MORSE A. S., BERMAN A. RELATIONSHIP OF HEMOSIDEROSIS TO PORTACAVAL SHUNTING. Surgery. 1963 Dec;54:912–921. [PubMed] [Google Scholar]
  24. DOBERNECK R. C., MORSE A. S., CONRAD M. E., BERMAN A. R. HEPATIC IRON STORAGE AND ERYTHROKINETICS AFTER PORTACAVAL SHUNT. Surgery. 1965 Jun;57:800–808. [PubMed] [Google Scholar]
  25. Davis P. S., Luke C. G., Deller D. J. Reduction of gastric iron-binding protein in haemochromatosis. A previously unrecognised metabolic defect. Lancet. 1966 Dec 31;2(7479):1431–1433. doi: 10.1016/s0140-6736(66)90594-0. [DOI] [PubMed] [Google Scholar]
  26. Dymock I. W., Cassar J., Pyke D. A., Oakley W. G., Williams R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med. 1972 Feb;52(2):203–210. doi: 10.1016/0002-9343(72)90070-8. [DOI] [PubMed] [Google Scholar]
  27. Dymock I. W., Hamilton E. B., Laws J. W., Williams R. Arthropathy of haemochromatosis. Clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis. 1970 Sep;29(5):469–476. doi: 10.1136/ard.29.5.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. ELLIS J. T., SCHULMAN I., SMITH C. H. Generalized siderosis with fibrosis of liver and pancreas in Cooley's (Mediterranean) anemia; with observations on the pathogenesis of the siderosis and fibrosis. Am J Pathol. 1954 Mar-Apr;30(2):287–309. [PMC free article] [PubMed] [Google Scholar]
  29. ETIENNE-MARTIN P., KLEPPING C., BINET J. [Hemochromatosis during thalassemia minor. (Associated pigmentary biliary lithiasis and duodenal ulcer. Terminal asystole)]. Arch Mal Appar Dig Mal Nutr. 1959 Jul-Aug;48:844–852. [PubMed] [Google Scholar]
  30. FINCH S. C., FINCH C. A. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis. Medicine (Baltimore) 1955 Dec;34(4):381–430. doi: 10.1097/00005792-195512000-00001. [DOI] [PubMed] [Google Scholar]
  31. FREY W. G., 3rd, MILNE J., JOHNSON G. B., Jr, EBAUGH F. G., Jr Management of familial hemochromatosis. N Engl J Med. 1961 Jul 6;265:7–12. doi: 10.1056/NEJM196107062650102. [DOI] [PubMed] [Google Scholar]
  32. Friedman B. I., Schaefer J. W., Schiff L. Increased iron-59 absorption in patients with hepatic cirrhosis. J Nucl Med. 1966 Aug;7(8):594–602. [PubMed] [Google Scholar]
  33. GOLBERG L., SMITH J. P. Iron overloading and hepatic vulnerability. Am J Pathol. 1960 Feb;36:125–149. [PMC free article] [PubMed] [Google Scholar]
  34. GREENBERG M. S., STROHMEYER G., HINE G. J., KEENE W. R., CURTIS G., CHALMERS T. C. STUDIES IN IRON ABSORPTION. III. BODY RADIOACTIVITY MEASUREMENTS OF PATIENTS WITH LIVER DISEASE. Gastroenterology. 1964 Jun;46:651–661. [PubMed] [Google Scholar]
  35. Gay J., Tchobroutsky G., Rosselin G., Assan R., Dolais J., Freychet P., Dérot M. Etude de huit cas d'hémochromatose primitive comportant en particulier le dosage radio-immunologique plasmatique des hormones somatotrope, folliculo-stimulante et du glucagon. Pathol Biol. 1968 Jan;16(1):53–60. [PubMed] [Google Scholar]
  36. Goldsworthy P. D., McCartor H. R., McGuigan J. E., Peppers G. F., Volwiler W. Relative albumin, transferrin, and fibrinogen synthesis rates in perfused bovine liver. Am J Physiol. 1970 May;218(5):1428–1433. doi: 10.1152/ajplegacy.1970.218.5.1428. [DOI] [PubMed] [Google Scholar]
  37. Goya N., Miyazaki S., Kodate S., Ushio B. A family of congenital atransferrinemia. Blood. 1972 Aug;40(2):239–245. [PubMed] [Google Scholar]
  38. Grace N. D., Balint J. A. Hemochromatosis associated with end-to-side portacaval anastomosis. Am J Dig Dis. 1966 May;11(5):351–358. doi: 10.1007/BF02233629. [DOI] [PubMed] [Google Scholar]
  39. HASKINS D., STEVENS A. R., Jr, FINCH S., FINCH C. A. Iron metabolism; iron stores in man as measured by phlebotomy. J Clin Invest. 1952 Jun;31(6):543–547. doi: 10.1172/JCI102639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. HEILMEYER L., KELLER W., VIVELL O., KEIDERLING W., BETKE K., WOEHLER F., SCHULTZE H. E. [Congenital atransferrinemia in a 7-year-old girl]. Dtsch Med Wochenschr. 1961 Sep 15;86:1745–1751. doi: 10.1055/s-0028-1113001. [DOI] [PubMed] [Google Scholar]
  41. HOFFBAUER F. W. Primary biliary cirrhosis. Observations on the natural course of the disease in 25 women. Am J Dig Dis. 1960 Apr;5:348–383. doi: 10.1007/BF02232356. [DOI] [PubMed] [Google Scholar]
  42. HORRIGAN D. L., HARRIS J. W. PYRIDOXINE-RESPONSIVE ANEMIA: ANALYSIS OF 62 CASES. Adv Intern Med. 1964;12:103–174. [PubMed] [Google Scholar]
  43. HOUSTON J. C., ZILKHA K. J. Haemochromatosis in a family. Guys Hosp Rep. 1955;104(3):262–267. [PubMed] [Google Scholar]
  44. Hynes M. The Iron Reserve of a Normal Man. J Clin Pathol. 1949 May;2(2):99–102. doi: 10.1136/jcp.2.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kent G., Popper H. Liver biopsy in diagnosis of hemochromatosis. Am J Med. 1968 Jun;44(6):837–841. doi: 10.1016/0002-9343(68)90083-1. [DOI] [PubMed] [Google Scholar]
  46. Koff R. S., Go T. B., Oliai A. Hepatic hemosiderosis after portacaval shunt surgery in alcoholic cirrhosis: a sometime thing. Gastroenterology. 1972 Nov;63(5):834–836. [PubMed] [Google Scholar]
  47. LEREBOULLET J., LEVILLAIN R., DEBESSE B. L'hépatosidérose; sa fréquence chez les alcooliques; etude statistique de 350 examens anatomiques. 1956 Jun 22-Jul 6Bull Mem Soc Med Hop Paris. 72(21-23):684–689. [PubMed] [Google Scholar]
  48. LLOYD H. M., POWELL L. W., THOMAS M. J. IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID. Lancet. 1964 Sep 12;2(7359):555–557. doi: 10.1016/s0140-6736(64)90619-1. [DOI] [PubMed] [Google Scholar]
  49. LOHR K., REINWEIN H. Konkordantes Auftreten von Lebercirrhose und Diabetes mellitus (Hämochromatose) bei eineiigen Zwillingen. Dtsch Arch Klin Med. 1952;200(1):53–66. [PubMed] [Google Scholar]
  50. Lipschitz D. A., Bothwell T. H., Seftel H. C., Wapnick A. A., Charlton R. W. The role of ascorbic acid in the metabolism of storage iron. Br J Haematol. 1971 Feb;20(2):155–163. doi: 10.1111/j.1365-2141.1971.tb07024.x. [DOI] [PubMed] [Google Scholar]
  51. Lisboa P. E. Experimental hepatic cirrhosis in dogs caused by chronic massive iron overload. Gut. 1971 May;12(5):363–368. doi: 10.1136/gut.12.5.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Luke C. G., Davis P. S., Deller D. J. Gastric iron binding in haemochromatosis, secondary iron overload, cirrhosis, and diabetes. Lancet. 1968 Oct 19;2(7573):844–846. doi: 10.1016/s0140-6736(68)91000-3. [DOI] [PubMed] [Google Scholar]
  53. Lundin P., Lundvall O., Weinfeld A. Iron storage in alcoholic fatty liver. Acta Med Scand. 1971 Jun;189(6):541–546. doi: 10.1111/j.0954-6820.1971.tb04419.x. [DOI] [PubMed] [Google Scholar]
  54. Lundvall O. The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores. Acta Med Scand. 1971 Jan-Feb;189(1-2):33–49. doi: 10.1111/j.0954-6820.1971.tb04337.x. [DOI] [PubMed] [Google Scholar]
  55. Lundvall O. The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda. Acta Med Scand. 1971 Jan-Feb;189(1-2):51–63. doi: 10.1111/j.0954-6820.1971.tb04338.x. [DOI] [PubMed] [Google Scholar]
  56. Lundvall O., Weinfeld A., Lundin P. Iron storage in porphyria cutanea tarda. Acta Med Scand. 1970 Jul-Aug;1-2(1):37–53. doi: 10.1111/j.0954-6820.1970.tb08003.x. [DOI] [PubMed] [Google Scholar]
  57. Lundvall O., Weinfeld A., Lundin P. Iron stores in alcohol abusers. I. Liver iron. Acta Med Scand. 1969 Apr;185(4):259–269. doi: 10.1111/j.0954-6820.1969.tb07332.x. [DOI] [PubMed] [Google Scholar]
  58. Lynch S. R., Berelowitz I., Seftel H. C., Miller G. B., Krawitz P., Charlton R. W., Bothwell T. H. Osteoporosis in Johannesburg Bantu males. Its relationship to siderosis and ascorbic acid deficiency. Am J Clin Nutr. 1967 Aug;20(8):799–807. doi: 10.1093/ajcn/20.8.799. [DOI] [PubMed] [Google Scholar]
  59. Lynch S. R., Seftel H. C., Torrance J. D., Charlton R. W., Bothwell T. H. Accelerated oxidative catabolism of ascorbic acid in siderotic Bantu. Am J Clin Nutr. 1967 Jun;20(6):641–647. doi: 10.1093/ajcn/20.6.641. [DOI] [PubMed] [Google Scholar]
  60. MACDONALD R. A., PECHET G. S. EXPERIMENTAL HEMOCHROMATOSIS IN RATS. Am J Pathol. 1965 Jan;46:85–109. [PMC free article] [PubMed] [Google Scholar]
  61. MacDonald R. A. Tissue iron and hemochromatosis. Comparative studies in Denver and Boston. Arch Pathol. 1967 Nov;84(5):543–551. [PubMed] [Google Scholar]
  62. Morgan E. H. Factors affecting the synthesis of transferrin by rat tissue slices. J Biol Chem. 1969 Aug 10;244(15):4193–4199. [PubMed] [Google Scholar]
  63. Morgan E. H., Walters M. N. Iron storage in human disease: Fractionation of hepatic and splenic iron into ferritin and haemosiderin with histochemical correlations. J Clin Pathol. 1963 Mar;16(2):101–107. doi: 10.1136/jcp.16.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Nixon D. D. Spontaneous shunt siderosis. Am J Dig Dis. 1966 May;11(5):359–366. doi: 10.1007/BF02233630. [DOI] [PubMed] [Google Scholar]
  65. Olsson K. S. Iron stores in normal men and male blood donors. As measured by desferrioxamine and quantitative phlebotomy. Acta Med Scand. 1972 Nov;192(5):401–407. doi: 10.1111/j.0954-6820.1972.tb04837.x. [DOI] [PubMed] [Google Scholar]
  66. PIRART J. DOUZE ANS DE RECUL DANS LE TRAITEMENT DE L'H'EMOCHROMATOSE PAR SAIGN'EES R'EP'ET'EES. Med Monde. 1964 Sep;40:170–175. [PubMed] [Google Scholar]
  67. PIRZIO-BIROLI G., BOTHWELL T. H., FINCH C. A. Iron absorption. II. The absorption of radioiron administered with a standard meal in man. J Lab Clin Med. 1958 Jan;51(1):37–48. [PubMed] [Google Scholar]
  68. PLOEM J. E., OTTEN K., HUIZINGA J., VERLOOP M. C. IDIOPATHIC HAEMOSIDEROSIS. Scand J Haematol. 1965;2:3–17. doi: 10.1111/j.1600-0609.1965.tb01274.x. [DOI] [PubMed] [Google Scholar]
  69. PRITCHARD J. A., MASON R. A. IRON STORES OF NORMAL ADULTS AND REPLENISHMENT WITH ORAL IRON THERAPY. JAMA. 1964 Dec 7;190:897–901. doi: 10.1001/jama.1964.03070230033008. [DOI] [PubMed] [Google Scholar]
  70. Perman G. Hemochromatosis and red wine. Acta Med Scand. 1967 Sep;182(3):281–284. doi: 10.1111/j.0954-6820.1967.tb11524.x. [DOI] [PubMed] [Google Scholar]
  71. Powell L. W., Campbell C. B., Wilson E. Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality. Gut. 1970 Sep;11(9):727–731. doi: 10.1136/gut.11.9.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Powell L. W. Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemosiderosis. A comparative study of 27 families. Q J Med. 1965 Oct;34(136):427–442. [PubMed] [Google Scholar]
  73. Powell L. W., Kerr J. F. Reversal of "cirrhosis" in idiopathic haemochromatosis following long-term intensive venesection therapy. Australas Ann Med. 1970 Feb;19(1):54–57. doi: 10.1111/imj.1970.19.1.54. [DOI] [PubMed] [Google Scholar]
  74. Powell L. W. Normal human iron storage and its relation to ethanol consumption. Australas Ann Med. 1966 May;15(2):110–115. doi: 10.1111/imj.1966.15.2.110. [DOI] [PubMed] [Google Scholar]
  75. Powell L. W., Wilson E. In-vivo intestinal mucosal uptake of iron, body iron absorption and gastric juice iron-binding in idiopathic haemochromatosis. Australas Ann Med. 1970 Aug;19(3):226–231. doi: 10.1111/imj.1970.19.3.226. [DOI] [PubMed] [Google Scholar]
  76. RUBIN E., KOHAN P., TOMITA F., JACOBSON J. H., 2nd EXPERIMENTAL HEPATIC SIDEROSIS FOLLOWING PORTACAVAL SHUNT. Proc Soc Exp Biol Med. 1964 Feb;115:350–352. doi: 10.3181/00379727-115-28910. [DOI] [PubMed] [Google Scholar]
  77. Risdon R. A., Flynn D. M., Barry M. The relation between liver iron concentration and liver damage in transfusional iron overload in thalassaemia and the effect of chelation therapy. Gut. 1973 May;14(5):421–421. [PubMed] [Google Scholar]
  78. Rubin E., Gevirtz N. R., Richter P., Jacobson J. H., 2nd Erythrocyte survival after experimental portacaval shunt. Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):1216–1217. doi: 10.3181/00379727-119-30417. [DOI] [PubMed] [Google Scholar]
  79. SCHAEFER J. W., AMICK C. J., OIKAWA Y., SCHIFF L. The development of hemochromatosis following portacaval anastomosis. Gastroenterology. 1962 Feb;42:181–188. [PubMed] [Google Scholar]
  80. SCHEUER P. J., WILLIAMS R., MUIR A. R. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol. 1962 Jul;84:53–64. [PubMed] [Google Scholar]
  81. SCHEUER P. J., WILLIAMS R., MUIR A. R. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol. 1962 Jul;84:53–64. [PubMed] [Google Scholar]
  82. SCHUMACHER H. R., Jr HEMOCHROMATOSIS AND ARTHRITIS. Arthritis Rheum. 1964 Feb;7:41–50. doi: 10.1002/art.1780070106. [DOI] [PubMed] [Google Scholar]
  83. SHODEN A., GABRIO B. W., FINCH C. A. The relationship between ferritin and hemosiderin in rabbits and man. J Biol Chem. 1953 Oct;204(2):823–830. [PubMed] [Google Scholar]
  84. SMITH R. S. CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA. Ann N Y Acad Sci. 1964 Oct 7;119:776–788. doi: 10.1111/j.1749-6632.1965.tb54079.x. [DOI] [PubMed] [Google Scholar]
  85. SPELLMAN F. A. LATENT HEMOCHROMATOSIS IN A TWIN. J Maine Med Assoc. 1965 Aug;56:181–183. [PubMed] [Google Scholar]
  86. Seftel H. C., Malkin C., Schmaman A., Abrahams C., Lynch S. R., Charlton R. W., Bothwell T. H. Osteoporosis, scurvy, and siderosis in Johannesburg bantu. Br Med J. 1966 Mar 12;1(5488):642–646. doi: 10.1136/bmj.1.5488.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Simon M., Franchimont P., Murie N., Ferrand B., van Cauwenberge H., Bourel M. Study of somatotropic and gonadotropic pituitary function in idiopathic haemochromatosis (31 cases). Eur J Clin Invest. 1972 Nov;2(6):384–389. doi: 10.1111/j.1365-2362.1972.tb00666.x. [DOI] [PubMed] [Google Scholar]
  88. Smith P. M., Godfrey B. E., Williams R. Iron absorption in idiopathic haemochromatosis and its measurement using a whole-body counter. Clin Sci. 1969 Oct;37(2):519–531. [PubMed] [Google Scholar]
  89. Stocks A. E., Martin F. I. Pituitary function in haemochromatosis. Am J Med. 1968 Dec;45(6):839–845. doi: 10.1016/0002-9343(68)90182-4. [DOI] [PubMed] [Google Scholar]
  90. Stocks A. E., Powell L. W. Pituitary function in idiopathic haemochromatosis and cirrhosis of the liver. Lancet. 1972 Aug 12;2(7772):298–300. doi: 10.1016/s0140-6736(72)92905-4. [DOI] [PubMed] [Google Scholar]
  91. Sturgeon P., Shoden A. Total liver storage iron in normal populations of the USA. Am J Clin Nutr. 1971 Apr;24(4):469–474. doi: 10.1093/ajcn/24.4.469. [DOI] [PubMed] [Google Scholar]
  92. TISDALE W. A. Parenchymal siderosis in patients with cirrhosis after portasystemic-shunt surgery. N Engl J Med. 1961 Nov 9;265:928–932. doi: 10.1056/NEJM196111092651903. [DOI] [PubMed] [Google Scholar]
  93. TURNBERG L. A. EXCESSIVE ORAL IRON THERAPY CAUSING HAEMOCHROMATOSIS. Br Med J. 1965 May 22;1(5446):1360–1360. doi: 10.1136/bmj.1.5446.1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. TUTTLE S. G., FIGUEROA W. G., GROSSMAN M. I. Development of hemochromatosis in a patient with Laennec's cirrhosis. Am J Med. 1959 Apr;26(4):655–658. doi: 10.1016/0002-9343(59)90287-6. [DOI] [PubMed] [Google Scholar]
  95. Turnbull A., Baker H., Vernon-Roberts B., Magnus I. A. Iron metabolism in porphyria cutanea tarda and in erythropoietic protoporphyria. Q J Med. 1973 Apr;42(166):341–355. [PubMed] [Google Scholar]
  96. WILLIAMS R., SCHEUER P. J., SHERLOCK S. The inheritance of idiopathic haemochromatosis. A clinical and liver biopsy study of 16 families. Q J Med. 1962 Jul;31:249–265. [PubMed] [Google Scholar]
  97. Wapnick A. A., Lynch S. R., Krawitz P., Seftel H. C., Charlton R. W., Bothwell T. H. Effects of iron overload on ascorbic acid metabolism. Br Med J. 1968 Sep 21;3(5620):704–707. doi: 10.1136/bmj.3.5620.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Wapnick A. A., Lynch S. R., Seftel H. C., Charlton R. W., Bothwell T. H., Jowsey J. The effect of siderosis and ascorbic acid depletion on bone metabolism, with special reference to osteoporosis in the Bantu. Br J Nutr. 1971 May;25(3):367–376. doi: 10.1079/bjn19710101. [DOI] [PubMed] [Google Scholar]
  99. Weinfeld A., Lundin P., Lundvall O. Significance for the diagnosis of iron overload of histochemical and chemical iron in the liver of control subjects. J Clin Pathol. 1968 Jan;21(1):35–40. doi: 10.1136/jcp.21.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Weintraub L. R., Conrad M. E., Crosby W. H. Iron-loading anemia. Treatment with repeated phlebotomies and pyridoxine. N Engl J Med. 1966 Jul 28;275(4):169–176. doi: 10.1056/NEJM196607282750401. [DOI] [PubMed] [Google Scholar]
  101. Weintraub L. R., Conrad M. E., Crosby W. H. The treatment of hemochromatosis by phlebotomy. Med Clin North Am. 1966 Nov;50(6):1579–1590. doi: 10.1016/s0025-7125(16)33106-6. [DOI] [PubMed] [Google Scholar]
  102. Williams R., Smith P. M., Spicer E. J., Barry M., Sherlock S. Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients. Q J Med. 1969 Jan;38(149):1–16. [PubMed] [Google Scholar]
  103. Wilson J. D., Scott P. J., North J. D. Hemochromatosis in association with hereditary spherocyto- sis. Arch Intern Med. 1967 Dec;120(6):701–707. [PubMed] [Google Scholar]
  104. Wynter C. V., Williams R. Iron-binding properties of gastric juice in idiopathic haemochromatosis. Lancet. 1968 Sep 7;2(7567):534–537. doi: 10.1016/s0140-6736(68)92407-0. [DOI] [PubMed] [Google Scholar]
  105. ZIMMERMAN H. J., CHOMET B., KULESH M. H., McWHORTER C. A. Hepatic hemosiderin deposits. Incidence in 558 biopsies from patients with and without intrinsic hepatic disease. Arch Intern Med. 1961 Apr;107:494–503. doi: 10.1001/archinte.1961.03620040020003. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES